ADHS Blog: Federal officials considering COVID-19 vaccines for kids as young as 6 months

Federal officials considering COVID-19 vaccines for kids as young as 6 months As a public health professional and mother of young children, I am happy to see the Food and Drug Administration (FDA) begin formal consideration of COVID-19 vaccination for children as young as 6 months. The key to this federal review is determining if the benefits of COVID-19 vaccination outweigh any potential adverse effects. The FDA Advisory Panel is scheduled to meet Wednesday, June 15, to decide whether to grant Emergency Use Authorization for a Pfizer vaccine for ages 6 months through 4 years and a Moderna vaccine for 6 months through 5 years of age. If the panel recommends the vaccines and the FDA director concurs, the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices would give its recommendation later this week. Approval from the CDC director would likely make these vaccines available early next week. Read the Blog

Stay connected with us:

Subscriber Services: Manage Subscriptions  |  Unsubscribe All  |  Help

Sent on behalf of the Arizona Department of Health Services using GovDelivery ∙ 150 North 18th Avenue, Phoenix, Arizona 85007 ∙ 602-542-1025 ∙ azhealth.gov